Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours

C. Marian, A. Scope, K. Laud, E. Friedman, F. Pavlotsky, E. Yakobson, B. Bressac-De Paillerets, E. Azizi

Research output: Contribution to journalArticlepeer-review

Abstract

To gain insight into the molecular mechanisms involved in the inherited predisposition to melanoma and associated neural system tumours, 42 Jewish, mainly Ashkenazi, melanoma families with or without neural system tumours were genotyped for germline point mutations and genomic deletions at the CDKN2A/ARF and CDK4 loci. CDKN2A/ARF deletion detection was performed using D9S1748, an intragenic microsatellite marker. Allele dosage at the p14ARF locus was analysed by quantitative real-time PCR employing a TaqMan probe that anneals specifically to exon 1β of the p14ARF gene. For detecting point mutations, dHPLC and direct sequencing of the coding sequences of CDKN2A/ARF and CDK4 was used. No germline alterations in any of the tested genes were detected among the families under study. We conclude that in the majority of Ashkenazi Jewish families, the genes tested are unlikely to be implicated in the predisposition to melanoma and associated neural system tumours.

Original languageEnglish
Pages (from-to)2278-2285
Number of pages8
JournalBritish Journal of Cancer
Volume92
Issue number12
DOIs
StatePublished - 20 Jun 2005

Keywords

  • Ashkenazi Jewish melanoma families
  • CDK4
  • CDKN2A/ARF
  • Germline mutations
  • Inherited predisposition
  • Neural system tumours

Fingerprint

Dive into the research topics of 'Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours'. Together they form a unique fingerprint.

Cite this